Tyra Biosciences (TYRA) Accounts Payables (2020 - 2026)
Quarterly Accounts Payables rose 45.68% to $3.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Mar 2026, up 45.68% year-over-year, with the annual reading at $1.2 million for FY2025, 99.66% up from the prior year.
Tyra Biosciences filings provide 7 years of Accounts Payables readings, the most recent being $3.6 million for Q1 2026.
- Accounts Payables hit $3.6 million in Q1 2026 for Tyra Biosciences, up from $1.2 million in the prior quarter.
- Across five years, Accounts Payables topped out at $4.7 million in Q4 2023 and bottomed at $590000.0 in Q4 2024.
- Average Accounts Payables over 5 years is $2.1 million, with a median of $2.0 million recorded in 2025.
- The largest annual shift saw Accounts Payables surged 307.16% in 2023 before it tumbled 87.34% in 2024.
- Tyra Biosciences' Accounts Payables stood at $1.1 million in 2022, then soared by 307.16% to $4.7 million in 2023, then tumbled by 87.34% to $590000.0 in 2024, then surged by 99.66% to $1.2 million in 2025, then skyrocketed by 209.17% to $3.6 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Accounts Payables are $3.6 million (Q1 2026), $1.2 million (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.03 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 3.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.64 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 590,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.58 Mn |
| Mar 31, 2024 | 2.88 Mn |
| Dec 31, 2023 | 4.66 Mn |
| Sep 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 2.75 Mn |
| Jun 30, 2022 | 2.34 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 599,000.00 |
| Sep 30, 2021 | 2.07 Mn |
| Dec 31, 2020 | 664,000.00 |